Gout - 58 Studies Found
| Completed |
: Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia : Gout : 2025-08-05 : dotinurad alone |
| Completed |
: Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare : Acute Gout : 2025-08-05 : 150 mg/1ml/bottle |
| Completed |
: PK Effects of SHR4640 on Repaglinide and Midazolam, and the Impact of SHR4640 on QT Interval : Gout and Hyperuricemia : 2025-08-05 : repaglinide; midazolam; SHR4640 |
| Completed |
: Probiotics for Gout / Hyperuricemia: A Randomized, Intervention, Parallel Controlled, Multicenter Clinical Trial : Gout : 2025-08-05 : Patients will be randomly assigned to the routine treatment + placebo group and probiotics + routine treatment group according to 1:2 ratio. |
| COMPLETED |
: Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001. : Gout : 2025-08-05 : Test the efficacy and safety of SAP 001 versus placebo |
| COMPLETED |
: Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination with Allopurinol in Patients with Tophaceous Gout : Gout : 2025-08-05 : Solid Oral Capsule |
| COMPLETED |
: A Bioequivalence Study of Two Different Dosage Form of Genakumab : Gouty Arthritis (GA) : 2025-08-05 : A single dose of subcutaneous injection of Genakumab?Solution for injection, liquid formulation?200 mg on Day 1 |
| COMPLETED |
: A Study to Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers with Elevated Uric Acid Levels : Gout : 2025-08-05 : Escalating doses of PRX-115 will be given in different cohorts i.e., Cohorts 1 through 8 |